ETR:COP - Compugroup Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
€46.58 -1.06 (-2.23 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close€47.64
Today's Range€45.80 - €47.72
52-Week Range€40.10 - €60.30
Volume91,866 shs
Average Volume68,245 shs
Market Capitalization$2.37 billion
P/E RatioN/A
Dividend Yield0.79%
BetaN/A
Compugroup Medical logoCompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks. This segment offers integrated software solutions for customers to manage, analyze, and use medical data; organize business operations; and generate invoices. Its Pharmacy Information Systems segment provides integrated clinical, administrative, and financial software applications for retail pharmacies. This segment also offers in-store and online merchandising programs. The company's Hospital Information Systems segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute hospitals; rehabilitation centers; and social services, including multi-site hospital networks and regional care organizations. Its Health Connectivity Services segment provides solutions that enable pharmaceutical companies to provide information to healthcare providers through software interfaces. This segment also offers clinical decision support systems, and drugs and therapy databases for healthcare providers; and solutions for personal health records, consumer portals, and mobile applications, as well as collects and mediates clinical data for market studies, clinical trials, etc. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical Aktiengesellschaft and changed its name to CompuGroup Medical Societas Europaea in February 2016. CompuGroup Medical Societas Europaea was founded in 1979 and is headquartered in Koblenz, Germany.

Receive COP News and Ratings via Email

Sign-up to receive the latest news and ratings for COP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange ETR
Industry Health Information Services
Sub-IndustryN/A
SectorComputer and Technology
SymbolETR:COP
CUSIPN/A
Phone+49-261-80000

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins3.15%
Return on Equity7.28%
Return on Assets2.13%

Miscellaneous

EmployeesN/A
Outstanding Shares49,720,000
Market Cap$2,370.00

Compugroup Medical (ETR:COP) Frequently Asked Questions

What is Compugroup Medical's stock symbol?

Compugroup Medical trades on the ETR under the ticker symbol "COP."

What price target have analysts set for COP?

6 equities research analysts have issued twelve-month price targets for Compugroup Medical's stock. Their predictions range from €46.00 to €60.00. On average, they expect Compugroup Medical's stock price to reach €53.67 in the next twelve months. This suggests a possible upside of 15.2% from the stock's current price. View Analyst Ratings for Compugroup Medical.

What is the consensus analysts' recommendation for Compugroup Medical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Compugroup Medical in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Who are some of Compugroup Medical's key competitors?

Who are Compugroup Medical's key executives?

Compugroup Medical's management team includes the folowing people:
  • Mr. Frank Gotthardt, Chairman of Management Board & CEO (Age 68)
  • Mr. Christian Bartlett Teig, CFO & Member of Management Board (Age 53)
  • Mr. Uwe Eibich, Exec. VP of Central Europe & Member of Management Board (Age 56)
  • Mr. Frank Brecher, Chief Process Officer & Member of Management Board (Age 48)
  • Dr. Dirk Thorsten Vogel, Sr. VP of Global Software & Services

Has Compugroup Medical been receiving favorable news coverage?

News articles about COP stock have been trending positive on Friday, according to Accern Sentiment. The research firm identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Compugroup Medical earned a media sentiment score of 0.37 on Accern's scale. They also assigned media headlines about the company an impact score of 46.69 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.

What is Compugroup Medical's stock price today?

One share of COP stock can currently be purchased for approximately €46.58.

How big of a company is Compugroup Medical?

Compugroup Medical has a market capitalization of $2.37 billion.

How can I contact Compugroup Medical?

Compugroup Medical's mailing address is Maria Trost 21, KOBLENZ, 56070, Germany. The company can be reached via phone at +49-261-80000.


MarketBeat Community Rating for Compugroup Medical (ETR COP)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  126 (Vote Outperform)
Underperform Votes:  96 (Vote Underperform)
Total Votes:  222
MarketBeat's community ratings are surveys of what our community members think about Compugroup Medical and other stocks. Vote "Outperform" if you believe COP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.